Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by Jefferam1on Sep 29, 2017 12:07pm

101 Views

Post# 26759067

RE:RE:Strange market

I agree with StrikingMoose statement.
I expect Oct 0.09-0.11, Nov 0.10 - 0.12, Dec 0.12-0.15+
Jan 0.15+ and possibly up to 0.75 - cha ching!

However on that note, I would not be surprised nor would I rush off if I seen the following:
Oct 0.08-0.10, Nov 0.08-0.12, Dec 0.10-0.15
Basically what I'm saying, if we see 0.08 in Sept, Oct and Nov, I won't be surprised.
I'll be surpsied if we see 0.08 in Dec.

I don't think we will ever see 0.075 but I will not rule that out and it will not scare me if we do see it in the next 2 months. (Buying oportunity).

No panic till mid Dec. If we see 0.075 on Dec 15, Then I'll start to panic.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading